Group 1 - HCA Healthcare reported quarterly earnings of $6.45 per share, exceeding the Zacks Consensus Estimate of $5.77 per share, and up from $5.36 per share a year ago, representing an earnings surprise of 11.79% [1] - The company posted revenues of $18.32 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.08%, and an increase from $17.34 billion year-over-year [2] - HCA shares have increased approximately 13.8% since the beginning of the year, contrasting with the S&P 500's decline of -6.8% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is $6.18 on revenues of $18.45 billion, and for the current fiscal year, it is $24.98 on revenues of $74.69 billion [7] - The Medical - Hospital industry, to which HCA belongs, is currently ranked in the top 10% of over 250 Zacks industries, indicating strong performance potential [8] Group 3 - HCA has surpassed consensus EPS estimates in all four of the last quarters, indicating consistent performance [2] - The estimate revisions trend for HCA is currently mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]
HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates